Northeast Financial Consultants Inc Takeda Pharmaceutical CO LTD Transaction History

Northeast Financial Consultants Inc

  • $2.25 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 30, 2020
SELL
$14.59 - $19.5 $395,709 - $528,879
-27,122 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$16.88 - $20.83 $444,315 - $548,287
-26,322 Reduced 49.25%
27,122 $535,000
Q2 2019

Aug 09, 2019
BUY
$16.58 - $20.49 $886,101 - $1.1 Million
53,444 New
53,444 $946,000

Others Institutions Holding TAK

# of Institutions
336
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email